*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Pirlimycin is a semi-synthetic lincosamide antibiotic derived from <strong>pirlimycin hydrochloride</strong>, primarily used in veterinary medicine. Its core synthesis involves the modification of lincomycin precursors to enhance stability against bacterial resistance. The compound features the molecular formula <strong>C21H40N2O7S</strong> and carries the CAS registry number <strong>59684-29-4</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Veterinary Therapeutics:</strong> Treatment of mastitis in dairy cattle caused by susceptible Staphylococcus aureus.</li>
<li><strong>Dairy Production:</strong> Intramammary infusion protocols for managing acute bovine mastitis infections.</li>
<li><strong>Pharmaceutical Manufacturing:</strong> Bulk supply for compounding specialized animal health formulations.</li>
</ul>
<h3>Precautions</h3>
<p>Strict adherence to withdrawal periods is mandatory to prevent drug residues in milk. Personnel must utilize appropriate PPE due to potential sensitization risks. Storage requires sealed containers at controlled temperatures below 25°C to maintain chemical integrity.</p>